1. Home
  2. COCP vs GXAI Comparison

COCP vs GXAI Comparison

Compare COCP & GXAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cocrystal Pharma Inc.

COCP

Cocrystal Pharma Inc.

HOLD

Current Price

$1.12

Market Cap

15.6M

Sector

Health Care

ML Signal

HOLD

Logo Gaxos.ai Inc.

GXAI

Gaxos.ai Inc.

HOLD

Current Price

$1.17

Market Cap

13.5M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
COCP
GXAI
Founded
2006
2021
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
15.6M
13.5M
IPO Year
2011
2022

Fundamental Metrics

Financial Performance
Metric
COCP
GXAI
Price
$1.12
$1.17
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$6.00
N/A
AVG Volume (30 Days)
118.8K
276.1K
Earning Date
05-15-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
54.65
71.35
EPS
N/A
N/A
Revenue
$12,712,091.00
$1,933,030.00
Revenue This Year
N/A
$271.23
Revenue Next Year
N/A
$36.32
P/E Ratio
N/A
N/A
Revenue Growth
N/A
47901.74
52 Week Low
$0.86
$1.02
52 Week High
$2.19
$2.96

Technical Indicators

Market Signals
Indicator
COCP
GXAI
Relative Strength Index (RSI) 37.96 45.40
Support Level $1.00 $1.04
Resistance Level $1.27 $1.31
Average True Range (ATR) 0.08 0.06
MACD -0.02 -0.00
Stochastic Oscillator 12.50 46.47

Price Performance

Historical Comparison
COCP
GXAI

About COCP Cocrystal Pharma Inc.

Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first and in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).

About GXAI Gaxos.ai Inc.

Gaxos.AI Inc is a technology company focused on reshaping the way people interact with artificial intelligence across everyday life and high-impact industries. It is engaged in building a portfolio of AI-powered solutions designed to make advanced technology more practical, accessible, and transformative. The company's portfolio spans defense, health and wellness, entertainment, and productivity - bringing intelligent tools to markets where innovation can drive meaningful real-world outcomes. It operates as a single operating segment technology-based company that is developing applications aimed at redefining the way it utilizes artificial intelligence (AI) to optimize the user experience.

Share on Social Networks: